SCHEMBL21216577

SCHEMBL21216577

CC(C)Cc1ccccc1OCC1CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 1/20 0.62
▸ KCNH2 Q12809 2/20 0.53
▸ SLC6A2 P23975 1/20 0.53
▸ SLC6A4 P31645 1/20 0.53
▸ SLC6A3 Q01959 1/20 0.53
▸ HTR2C P28335 3/20 0.42
▸ GABRA1 P14867 1/20 0.39
▸ GABRB2 P47870 1/20 0.39
▸ HTR1A P08908 4/20 0.37
▸ ADRA2A P08913 4/20 0.37
▸ ADRA2B P18089 4/20 0.37
▸ ADRA2C P18825 4/20 0.37
▸ PDE4A P27815 2/20 0.37
▸ PDE4B Q07343 2/20 0.37
▸ PDE4C Q08493 2/20 0.37
▸ PDE4D Q08499 2/20 0.37
▸ PDE5A O76074 1/20 0.37
▸ P2RX3 P56373 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ GLA P06280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24180094 0.94 RIPK1 (0.55) RIPK1KCNH2SLC6A2SLC6A4SLC6A3
SCHEMBL561124 0.81 RIPK1 (0.63) RIPK1KCNH2SLC6A2SLC6A4SLC6A3
SCHEMBL284472 0.81 ALDH1A1 (0.61) RIPK1KCNH2SLC6A2SLC6A4SLC6A3
SCHEMBL24309358 0.80 RIPK1 (0.51) RIPK1KCNH2SLC6A2SLC6A4SLC6A3
SCHEMBL22957616 0.80 RIPK1 (0.57) RIPK1KCNH2SLC6A2SLC6A4SLC6A3
SCHEMBL560790 0.77 RIPK1 (0.63) RIPK1KCNH2SLC6A2SLC6A4SLC6A3
SCHEMBL8549973 0.77 RIPK1 (0.63) RIPK1KCNH2SLC6A2SLC6A4SLC6A3
SCHEMBL8252603 0.77 RIPK1 (0.63) RIPK1KCNH2SLC6A2SLC6A4SLC6A3
SCHEMBL22095406 0.77 RIPK1 (0.51) RIPK1KCNH2SLC6A2SLC6A4SLC6A3
SCHEMBL22095407 0.77 RIPK1 (0.51) RIPK1KCNH2SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019147782-A1 AMINOPYRROLOTRIAZINES AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2019-08-01 — — WO disclosed
Send feedback